Therapeutic interventions for nephropathy in type I diabetes mellitus

• Published in: Seminars in nephrology Vol. 17; no. 2; p. 114
• Main Author: Breyer, J A
• Format: Journal Article
• Language: English
• Published: United States 01.03.1997
• Subjects: Aldehyde Reductase - antagonists & inhibitors; Angiotensin-Converting Enzyme Inhibitors - therapeutic use; Animals; Diabetes Mellitus, Type 1 - complications; Diabetic Nephropathies - etiology; Diabetic Nephropathies - therapy; Dietary Proteins - administration & dosage; Glycation End Products, Advanced - antagonists & inhibitors; Humans; Hypolipidemic Agents - therapeutic use

Diabetic nephropathy is the single most common cause of end-stage renal disease in the United States. Recently, several major therapeutic interventions have been developed and shown to slow or halt the progression of renal failure in patients with diabetes and diabetic kidney disease. Studies have s...